Health Catalyst Stock Filter Stocks by Fundamentals
| HCAT Stock | USD 8.13 0.00 0.00% |
Health Catalyst fundamentals help investors to digest information that contributes to Health Catalyst's financial success or failures. It also enables traders to predict the movement of Health Stock. The fundamental analysis module provides a way to measure Health Catalyst's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Health Catalyst stock.
Health | Shares Owned by Institutions |
Health Catalyst Current Valuation Drivers
We derive many important indicators used in calculating different scores of Health Catalyst from analyzing Health Catalyst's financial statements. These drivers represent accounts that assess Health Catalyst's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Health Catalyst's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 650.3M | 1.7B | 1.9B | 571.1M | 522.4M | 496.3M | |
| Enterprise Value | 684.9M | 1.8B | 1.9B | 702.7M | 665.2M | 1.2B |
Health Catalyst ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Health Catalyst's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Health Catalyst's managers, analysts, and investors.Environmental | Governance | Social |
Health Catalyst Institutional Holders
Institutional Holdings refers to the ownership stake in Health Catalyst that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Health Catalyst's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Health Catalyst's value.| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.4 M | Kennedy Capital Management Inc | 2024-06-30 | 1.3 M | Jpmorgan Chase & Co | 2024-06-30 | 1.2 M | State Street Corp | 2024-06-30 | 1.1 M | Granahan Investment Management Inc.. | 2024-06-30 | 1 M | Alyeska Investment Group, L.p. | 2024-06-30 | 984.6 K | Goldman Sachs Group Inc | 2024-06-30 | 888.2 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 886.3 K | Invenomic Capital Management, Lp | 2024-06-30 | 850.6 K | Blackrock Inc | 2024-06-30 | 5.4 M | Vanguard Group Inc | 2024-09-30 | 4.6 M |
Health Fundamentals
| Return On Equity | -0.21 | ||||
| Return On Asset | -0.0526 | ||||
| Profit Margin | (0.26) % | ||||
| Operating Margin | (0.16) % | ||||
| Current Valuation | 424.91 M | ||||
| Shares Outstanding | 60.85 M | ||||
| Shares Owned By Insiders | 2.77 % | ||||
| Shares Owned By Institutions | 90.76 % | ||||
| Number Of Shares Shorted | 2.84 M | ||||
| Price To Earning | (2.62) X | ||||
| Price To Book | 1.26 X | ||||
| Price To Sales | 1.54 X | ||||
| Revenue | 295.94 M | ||||
| Gross Profit | 135.56 M | ||||
| EBITDA | (66.46 M) | ||||
| Net Income | (118.15 M) | ||||
| Cash And Equivalents | 403.35 M | ||||
| Cash Per Share | 7.37 X | ||||
| Total Debt | 249.07 M | ||||
| Debt To Equity | 0.53 % | ||||
| Current Ratio | 5.15 X | ||||
| Book Value Per Share | 5.83 X | ||||
| Cash Flow From Operations | (33.08 M) | ||||
| Short Ratio | 6.87 X | ||||
| Earnings Per Share | (1.34) X | ||||
| Target Price | 11.54 | ||||
| Number Of Employees | 1.3 K | ||||
| Beta | 1.33 | ||||
| Market Capitalization | 466.09 M | ||||
| Total Asset | 701.81 M | ||||
| Retained Earnings | (1.12 B) | ||||
| Working Capital | 304.36 M | ||||
| Current Asset | 216.75 M | ||||
| Current Liabilities | 48.69 M | ||||
| Net Asset | 701.81 M |
About Health Catalyst Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Health Catalyst's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Health Catalyst using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Health Catalyst based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Health Stock Analysis
When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.